GET THE APP

Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

+44 1223 790975

Chemotherapy: Open Access : Citations & Metrics Report

Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

30 8 0 17 24 52

Year wise citations received

61 68 83 58 143 116
Journal total citations count 709
Journal impact factor 1.81
Journal 5 years impact factor 3.80
Journal cite score 4.89
Journal h-index 12
Journal h-index since 2018 9
Important citations (402)

satya srinivas v. research and reviews: journal of medical and health sciences.

anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102.

alshehri af, alnatsheh a, aseeri m, al fayea t. evaluation of the use of granulocyte colony-stimulating factors (g-csfs) for neutropenia primary prophylaxis in solid tumors at a tertiary care hospital, retrospective study. j pharmacovigil. 2017;5(248):2.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

rachana n. research & reviews: journal of pharmaceutics and nanotechnology.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

rachana n. research & reviews: journal of pharmaceutics and nanotechnology.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

bala r, sharma d, kaur a. research & reviews: journal of medical and health sciences.

kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

Relevant Topics

Top